MYX 1.05% $4.72 mayne pharma group limited

doi: 10.1080/13625187.2017.1336532Their new oral contraceptive...

  1. 76 Posts.
    lightbulb Created with Sketch. 32
    doi: 10.1080/13625187.2017.1336532
    Their new oral contraceptive Nextstellis passed Phase 3 trials and now before FDA for final approval. It is the first oral contraceptive with a natural estrogen (present in fetal liver) to be available in 5 years. Studies show women who take is have less weight gain (this is going to be a decider).

    https://doi.org/10.1080/13625187.2017.1336532

    if approved, will be very strong news.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.72
Change
-0.050(1.05%)
Mkt cap ! $401.5M
Open High Low Value Volume
$4.78 $4.84 $4.68 $1.898M 400.6K

Buyers (Bids)

No. Vol. Price($)
3 2539 $4.71
 

Sellers (Offers)

Price($) Vol. No.
$4.73 113 1
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
$4.71
  Change
-0.050 ( 1.95 %)
Open High Low Volume
$4.79 $4.84 $4.68 99621
Last updated 15.59pm 07/06/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.